4 February 2019
Researchers and opinion leaders have considered a number of potential solutions to the so-called antibody-related reproducibility crisis. One is to transition from traditional monoclonal antibodies to recombinant antibodies. So, what makes recombinant antibodies better than conventional hybridoma-derived antibodies? Six flow cytometry experts share their opinions and experiences with us in this video.